Is ketamine the answer to treatment-resistant depression?
While once considered a counterculture drug, ketamine is now giving hope for patients with treatment-resistant depression.
The University of Cincinnati's Stephen Rush, MD, treats patients with intranasal ketamine and esketamine in the Treatment Resistant Depression Clinic and joined WVXU's Cincinnati Edition to discuss the drugs' benefits and the importance of administering the drug in a safe and controlled setting.
Rush explained ketamine was initially developed as an anesthetic, and its "mirror image" molecule esketamine has been approved by the FDA for treatment-resistant depression.
"Ketamine or esketamine impact an entirely different molecule in the brain (than traditional antidepressants)," said Rush, associate professor of clinical psychiatry in UC's College of Medicine and medical director of ambulatory services. "Ketamine increases the neuroplasticity of the brain. That is, it increases the ability of our nervous system to change its activity by reorganizing its structure, functions and connections with other parts of the brain, going from a function causing depression to a function in which depression is no longer present."
Rush said administering intranasal ketamine and esketamine in the clinic is structured with safety in mind, as vital signs like heart rate and blood pressure are monitored, side effects are reported and patients stay for 2-4 hours after treatment to confirm their vital signs are in normal range and they are safe to be discharged.
"My personal opinion is that the data on safety around home-use ketamine is not there yet, and I would generally advise against it," Rush said. "Certainly someone who is participating in treatment in our clinics cannot also be getting home treatment through another service."
Since the use of ketamine or esketamine is focused on people who have failed traditional treatments, Rush said it is exciting to see patients entering remission from depression through this treatment. Meta-analyses of studies have found likelihood of remission with esketamine treatment is about 30-45%, while likelihood of having at least a 50% reduction in symptoms is about 40-55%.
"I often hear about patients telling me about how life has changed, whether that means going back to work and coming off of disability, or going back to school, engaging in relationships in ways they haven’t for years and generally functioning," Rush said. "Not only are we talking about the improvement in mood, we’re talking about the increase in functioning and the person’s ability to contribute to society and be productive, which is a huge factor in determining someone's sense of wellness."
Listen to the Cincinnati Edition segment.
Featured photo at top of ketamine vial. Photo/Jennifer Fontan/iStock.
Latest UC News
- Is there a link between hotter temps and increased migraine headaches?Dr. Vincent Martin, professor in the UC College of Medicine, presents research at the annual American Headache Society meeting showing that as temperatures rise so do the chances for migraine attacks.
- UC Police receive award for excellence in crisis interventionThe University of Cincinnati Police Division (UCPD) was recently named the Crisis Intervention Team (CIT) Department of the Year by Mental Health America (MHA) of Northern Kentucky and Southwest Ohio.
- Two-spirit and intersex people explain they/them pronounsDelia Sosa, a medical student at the University of Cincinnati College of Medicine, spoke with Spectrum News as part of the station's Pride month coverage. Sosa discussed the use of they/them pronouns and more about transgender and non-binary communities.
- Choir director uses synesthesia to inspire, lead Little Miami High School choirThe University of Cincinnati's Daniel Sun was featured in a WLWT story about a local choir teacher with synesthesia, a condition where two senses overlap in the brain.
- UC creates voice-coaching app for gender expressionEngineers at the University of Cincinnati have developed a free voice-coaching app to help transgender and gender-diverse people sound more masculine or feminine.
- Lab Safety Institute, UC team up for summitUC College of Arts and Sciences Dean James Mack talks to Fox19 about how UC is helping teachers make labs safer for their K-12 students.